Clinical Trial Update: Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer [NA]

View source ↗

Summary

Phase I trial evaluating a contralateral esophagus sparing technique (CEST) for IMRT in locally advanced lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma | NA | Status: COMPLETED | Results posted: 2020-02-24